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Acute Lps sensitization and 
continuous infusion exacerbates 
hypoxic brain injury in a piglet 
model of neonatal encephalopathy
Kathryn A. Martinello  1,2, Christopher Meehan1, Adnan Avdic-Belltheus1, Ingran Lingam1, 
sara Ragab1, Mariya Hristova1, Cally J. tann1,3, Donald peebles1, Henrik Hagberg4,5, 
tim G. A. M. Wolfs6, Nigel Klein7, Ilias tachtsidis8, Xavier Golay  9, Boris W. Kramer6, 
Bobbi Fleiss  5,10, Pierre Gressens5,10 & Nicola J. Robertson  1,11
Co-existing infection/inflammation and birth asphyxia potentiate the risk of developing neonatal 
encephalopathy (NE) and adverse outcome. In a newborn piglet model we assessed the effect of  
E. coli lipopolysaccharide (LPS) infusion started 4 h prior to and continued for 48 h after hypoxia on brain 
cell death and systemic haematological changes compared to Lps and hypoxia alone. Lps sensitized 
hypoxia resulted in an increase in mortality and in brain cell death (TUNEL positive cells) throughout 
the whole brain, and in the internal capsule, periventricular white matter and sensorimotor cortex. 
LPS alone did not increase brain cell death at 48 h, despite evidence of neuroinflammation, including 
the greatest increases in microglial proliferation, reactive astrocytosis and cleavage of caspase-3. LPS 
exposure caused splenic hypertrophy and platelet count suppression. the combination of Lps and 
hypoxia resulted in the highest and most sustained systemic white cell count increase. These findings 
highlight the significant contribution of acute inflammation sensitization prior to an asphyxial insult on 
NE illness severity.
Intrapartum-related neonatal encephalopathy (NE) is estimated to affect 1.16 million babies per year, causing 
287,000 deaths and resulting in 50.2 million disability adjusted life years1. NE is a clinical diagnosis encompass-
ing a constellation of disordered neurological function in the newborn. Intra-partum related NE refers to NE 
attributable to complications around the time of birth1,2. The aetiology of NE is multifactorial; as well as senti-
nel hypoxic-ischemic events, antenatal and placental pathology3, genetic susceptibility4 and perinatal infection/
inflammation5 contribute to brain injury and adverse outcomes6.
Antenatal inflammation is an established independent risk factor for the development of life long brain 
injury7–9. Epidemiological and observational clinical studies have associated perinatal inflammation with NE 
incidence and outcome. Clinical factors linked with inflammation, including prolonged rupture of membranes10 
and maternal fever3,11,12 are associated with NE. Histological chorioamnionitis and funisitis are more commonly 
found in the placentas of term infants with NE compared with healthy term controls12–15. Fetal inflammation, 
leading to raised pro-inflammatory cytokines at birth, is associated with higher risks of cerebral palsy (CP) and 
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adverse neurological sequelae in NE cohorts16,17. The combination of antenatal inflammation and clinically 
defined ‘birth asphyxia’ increases the risk of long term neurological impairment compared with either in iso-
lation8,18. A number of rodent pre-clinical studies, using infection simulants such as lipopolysaccharide (LPS), 
demonstrate that acute infection and inflammation before hypoxia-ischemia (HI) (termed “sensitization”) lower 
the injury threshold and exacerbate brain injury19–25.
Previous studies in our newborn piglet model have used a HI insult without prior infection or inflammation26–28. 
Our aim for this study was to develop and characterize a novel large-animal model of inflammation-sensitized term 
intrapartum-related NE. We hypothesized that the combination of LPS (commenced 4 h before index hypoxia) and 
hypoxia would exacerbate brain injury measured by overall TUNEL positive (TUNEL+) cells compared to either 
intervention alone. The overall aim of the study was to compare LPS, Hypoxia and LPS + Hypoxia groups over 52 h 
for: (i) physiological changes; (ii) morbidity and mortality; (iii) amplitude integrated EEG (aEEG) background activity 
recovery over 48 h, which is a predictor of outcome in babies with NE29; (iv) histological assessment of TUNEL+ cell 
death in 8 brain regions at 48 h after hypoxia; and (v) systemic haematological changes. Naïve and Sham groups were 
included for comparisons. Escherichia (E. coli) LPS, a component of the cell wall of gram-negative bacteria and a potent 
endotoxin, was given to simulate perinatal gram-negative infection and inflammation. We used an established piglet 
model that replicates neonatal intensive care monitoring and control of physiological and metabolic parameters. This 
model has strong similarities to newborn infants with NE in terms of the timing of the evolution of injury after HI, 
pattern of injury and neuropathology30,31.
Results
Baseline characteristics and physiological parameters. Twenty-six male piglets aged <36 h were 
studied. One additional LPS piglet was excluded due to an LPS dosing error. Physiological parameters are shown 
in Table 1. Mean piglet weight (1960 g; range 1650–2100 g) was similar between groups (p = 0.216). At baseline, 
the mean arterial pH for the Hypoxia group was high, owing to increased CO2 clearance. After 4 h LPS infusion, 
immediately prior to hypoxia, MABP was higher in the LPS + Hypoxia group than for the saline treated Hypoxia 
group (p = 0.01). Immediately following insult, the Hypoxia and LPS + Hypoxia group had similarly elevated 
lactate and BE, and reduced pH and pO2, as expected in response the hypoxia. All other significant intergroup 
differences throughout the experiment were within target physiological range.
Hypoxic insult. Insult severity (determined by duration of hypoxia, duration of hypotension and thus 
ischemia (MABP <30 mmHg), duration of isoelectric EEG and area under the curve (AUC) FiO2) was similar 
between groups (Table 2). There was a trend towards a shorter duration of EEG <5 µV (min) in the LPS + Hypoxia 
group compared to the Hypoxia group (p = 0.07). End of insult blood gases were similar between groups.
survival and clinical illness severity. Three of the five LPS + Hypoxia piglets died prior to experiment 
completion compared with none in the other groups (p = 0.022). One piglet died within minutes of insult cessa-
tion during the resuscitation phase: this piglet’s brain was the only one not obtained for later histological analysis. 
Two further piglets arrested at approximately 24 h with preceding refractory hypotension. One LPS and one 
Hypoxia piglet suffered respiratory arrests due to mechanical airway obstruction/equipment failure. Both were 
promptly resuscitated and completed the full duration of the experiment.
There was no significant difference in inotrope or saline bolus requirement between groups (Table 3). T-test 
comparison of hypoxia exposed versus non-exposed demonstrated greater doses of dopamine, dobutamine, 
adrenaline and saline for hypoxia exposed piglets (p = 0.019, p = 0.046, p = 0.031 and p = 0.011 respectively), 
although this study was not powered to detect differences in peripheral outcome measures. LPS exposure did not 
effect overall inotrope requirement (p ≥ 0.42). One Sham, one LPS and two Hypoxia piglets needed no inotropes. 
All piglets in the LPS + Hypoxia group required inotropes due to hypotension following the insult.
TUNEL. Estimated mean TUNEL+ cell counts were similar for Naïve, Sham and LPS groups (Fig. 1a). The 
Hypoxia group TUNEL+ count was increased versus LPS, Sham and Naïve (p ≤ 0.004). LPS + Hypoxia had 
greater histological cell death than all other groups (p < 0.0001 versus Naïve, Sham, LPS and p = 0.011 versus 
Hypoxia). Representative photomicrographs from the internal capsule at 40x magnification are shown in Fig. 1b.
Regional comparisons are shown in Fig. 1c. LPS + Hypoxia had increased cell death in the internal capsule 
and periventricular white matter versus Naïve, Sham and LPS, and in the sensorimotor cortex versus Naïve and 
LPS (p ≤ 0.04). Hypoxia group had greater cell death in the internal capsule versus Naïve and LPS, and in the 
periventricular white matter versus Naïve (p ≤ 0.047).
Cleaved Caspase-3. All groups, except Hypoxia, had a significant increase in CC3 positive cells compared 
with Naïve (Fig. 2a). CC3 staining was maximal for LPS, greater than all other groups (p ≤ 0.0001). The addi-
tion of hypoxia to LPS reduced CC3 count to be equivalent to Sham, but was still greater than Hypoxia alone 
(p = 0.044). On post hoc analysis, there was no correlation between CC3 positive and TUNEL+ cell count 
(rs = 0.113).
Microglia. Overall and regional brain IBA1 cell count (2b) and ramification index (2c) are shown in Fig. 2. 
Representative examples of microglia (IBA1 staining) are shown in Fig. 3. Microglia count was increased for LPS 
and LPS + Hypoxia, compared with Naïve and Hypoxia, and for LPS versus Sham (p ≤ 0.034). The microglial 
ramification index is a measure of microglial activation; activated microglia become amoeboid with fewer pro-
cesses and therefore a lower ramification index. LPS alone did not alter ramification index compared to Sham 
and Naïve. Mean ramification index was lower for Hypoxia and LPS + Hypoxia compared with other groups 
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Sham LPS Hypoxia LPS + Hypoxia
p value
n = 3 n = 5 n = 6 n = 5*
Mean (SD) Mean (SD) Mean (SD) Mean (SD) n
Temperature (°C)
Baseline 38.3 (0.5) 38.7 (0.9) 38.3 (0.8) 38.4 (0.3) 5 0.82
4 h LPS 39.0 (0.1) 38.9 (0.1) 39.0 (0.3) 38.9 (0.1) 5 0.63
End of insult 
(t = 0) 38.8 (0.2) 38.6 (0.2) 38.5 (0.3) 38.1 (0.3) 4 0.013*
1–2 h 38.8 (0.2) 38.4 (0.2) 39.0 (0.3) 38.8 (0.3) 4 0.007*
2–26 h 38.6 (0.0) 38.3 (0.2) 38.5 (0.3) 38.5 (0.1) 4 0.11
26–48 h 38.5 (0.2) 38.4 (0.2) 38.4 (0.2) 38.3 (0.0) 3 0.69
Heart rate (bpm)
Baseline 178 (15) 179 (17) 170 (10) 176 (19) 5 0.76
4hLPS 193 (34) 210 (18) 186 (15) 208 (8) 5 0.13
End of insult 
(t = 0) 189 (30) 218 (20) 209 (9) 222 (14) 4 0.13
1–2 h 187 (22) 208 (19) 217 (16) 224 (12) 4 0.07
2–26 h 178 (11) 207 (22) 201 (32) 210 (17) 4 0.35
26–48 h 162 (15) 175 (28) 166 (46) 175 (11) 3 0.93
Blood Pressure (mmHg)
Baseline 52 (5) 50 (4) 46 (6) 55 (4) 5 0.035*
4 h LPS 45 (6) 50 (6) 43 (4) 54 (3) 5 0.01*
End of insult 
(t = 0) 40 (5) 45 (9) 50 (10) 50 (24) 4 0.72
1–2 h 39 (6) 44 (9) 45 (10) 47 (19) 4 0.83
2–26 h 46 (4) 49 (2) 46 (4) 42 (6) 4 0.14
26–48 h 50 (5) 55 (4) 52 (6) 55 (3) 3 0.53
pH
Baseline 7.40 (0.02) 7.38 (0.08) 7.55 (0.09) 7.43 (0.05) 5 0.012*
4hLPS 7.49 (0.07) 7.40 (0.08) 7.49 (0.08) 7.42 (0.05) 5 0.15
End of insult 
(t = 0) 7.45 (0.03) 7.46 (0.10) 7.10 (0.13) 7.09 (0.05) 4 0.000*
12 h 7.47 (0.04) 7.48 (0.10) 7.47 (0.13) 7.49 (0.09) 4 0.99
24 h 7.50 (0.03) 7.41 (0.04) 7.45 (0.04) 7.27 (0.29) 4 0.17
48 h 7.45 (0.01) 7.47 (0.07) 7.42 (0.05) 7.49 (0.08) 3 0.35
pCO2 (kPa)
Baseline 5.8 (0.2) 6.8 (1.6) 4.4 (0.7) 6.2 (1.1) 5 0.015*
4hLPS 5.0 (0.3) 6.3 (1.1) 5.4 (1.0) 5.6 (0.7) 5 0.23
End of insult 
(t = 0) 5.2 (0.2) 5.9 (1.6) 6.0 (1.0) 5.6 (1.2) 4 0.41
12 h 5.1 (0.4) 5.3 (1.1) 6.2 (2.6) 4.9 (0.6) 4 0.62
24 h 4.7 (0.4) 6.2 (0.4) 5.1 (1.3) 4.7 (0.3) 4 0.07
48 h 5.2 (0.6) 5.0 (0.7) 5.5 (0.9) 4.5 (0.2) 3 0.33
pO2 (kPa)
Baseline 16.6 (9.1) 13.6 (3.6) 10.7 (1.1) 15.1 (4.9) 5 0.29
4hLPS 12.9 (2.7) 10.8 (1.7) 11.1 (1.8) 10.1 (0.9) 5 0.23
End of insult 
(t = 0) 12.9 (2.7) 12.0 (0.6) 6.8 (3.5) 7.4 (3.5) 4 0.032*
12 h 13.2 (0.9) 12.9 (2.5) 14.3 (5.2) 11.5 (0.7) 4 0.66
24 h 13.7 (1.5) 9.0 (0.6) 10.5 (1.9) 10.6 (3.2) 4 0.047*
48 h 13.4 (0.3) 11.9 (3.2) 12.2 (2.2) 13.0 (2.5) 3 0.85
Base Excess (mmol/L)
Baseline 2.3 (2.1) 5.2 (2.2) 6.2 (2.9) 6.2 (1.9) 5 0.15
4hLPS 3.3 (3.5) 4.0 (1.4) 6.3 (1.8) 2.8 (2.2) 5 0.07
End of insult 
(t = 0) 3.3 (2.9) 6.5 (0.7) −15.3 (5.9) −17 (2.9) 4 0.000*
12 h 5.0 (2.6) 6.4 (3.5) 8.3 (1.2) 4.5 (5.8) 4 0.36
24 h 4.7 (3.5) 4.6 (2.3) 2.5 (5.9) −7.8 (14.9) 4 0.13
48 h 3.0 (3.0) 2.8 (1.5) 2.3 (5.5) 2.5 (4.9) 3 0.99
Lactate (mmol/L)
Continued
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Sham LPS Hypoxia LPS + Hypoxia
p value
n = 3 n = 5 n = 6 n = 5*
Mean (SD) Mean (SD) Mean (SD) Mean (SD) n
Baseline 3.6 (1.3) 4.0 (1.4) 5.6 (1.2) 3.4 (1.4) 5 0.07
4 h LPS 3.3 (0.6) 4.4 (0.7) 4.2 (1.1) 5.4 (1.6) 5 0.12
End of insult 
(t = 0) 3.3 (0.9) 4.1 (0.8) 16 (2.9) 15.9 (0.8) 4 0.000*
12 h 1.7 (0.3) 3.0 (1.1) 2.6 (0.7) 5.2 (3.5) 4 0.084
24 h 1.7 (0.1) 1.6 (0.3) 4.3 (3.9) 9.3 (8.0) 4 0.08
48 h 1.6 (0.3) 0.9 (0.3) 1.5 (0.8) 1.1 (0.3) 3 0.28
Glucose (mmol/L)
Baseline 4.7 (1.6) 6.9 (1.2) 5.8 (1.1) 5.2 (1.9) 5 0.18
4 h LPS 7.0 (0.9) 7.0 (1.6) 8.6 (1.4) 6.5 (2.2) 5 0.36
End of insult 
(t = 0) 6.2 (0.6) 6.7 (1.3) 10.7 (2.9) 10.5 (3.8) 4 0.09
12 h 5.7 (0.6) 5.8 (0.9) 7.4 (1.6) 6.6 (1.3) 4 0.17
24 h 5.1 (0.9) 6.1 (0.4) 9.4 (5.6) 9.2 (3.7) 4 0.29
48 h 5.1 (1.0) 5.5 (0.3) 6.3 (1.7) 5.4 (0.8) 3 0.52
Potassium (mmol/L)
Baseline 4.2 (0.6) 4.6 (0.6) 5 (0.6) 4.5 (0.6) 5 0.38
4 h LPS 5.3 (0.4) 5.0 (0.5) 5.3 (0.7) 5.1 (0.8) 5 0.87
End of insult 
(t = 0) 5.3 (0.3) 5.3 (0.6) 5.2 (0.8) 5.3 (0.4) 4 0.99
12 h 6.1 (0.7) 7.1 (0.7) 6.8 (0.9) 7.7 (0.6) 4 0.09
24 h 6.4 (0.4) 6.5 (1.1) 7.3 (1.5) 8.0 (1.3) 4 0.24
48 h 4.1 (0.4) 4.9 (1.1) 7.1 (1.9) 5.3 (1.5) 3 0.044*
Table 1. Physiological parameters. Physiological observations and arterial blood gas results during the 
experiment, mean values and standard deviation (SD). The LPS + Hypoxia column lists number of animals (n) 
included in each analysis, which decreases over time due to mortality in this group. p values presented are from 
an ANOVA. All p values < 0.05, except 48 h potassium, maintained significance following a post hoc Tukey-
Kramer correction for multiple comparisons (bold indicates involved values).
Hypoxia LPS + Hypoxia p value
Duration (min) 32 (10) 24.4 (4.5) 0.14
AUC FiO2 (%) 468 (177) 357 (67) 0.17
Duration of EEG <5 μV (min) 27.3 (9.6) 16.4 (6.9) 0.07
Duration of MABP <30 mmHg (min) 15 (8.2) 8.8 (4.8) 0.16
End of Insult Arterial Gas:
pH 7.10 (0.13) 7.09 (0.03) 0.92
pCO2 (kPa) 6.0 (1.0) 5.6 (1.2) 0.56
Base Excess (mmol/l) −15.3 (5.9) −17 (2.9) 0.62
Lactate (mmol/L) 16.0 (2.9) 15.9 (0.8) 0.93
Table 2. Insult severity. Markers of insult severity, mean with standard deviation (SD). There was no significant 
difference between insult severity parameters between the Hypoxia and LPS + Hypoxia groups. AUC = area 
under the curve, MABP = mean arterial blood pressure.
Sham LPS Hypoxia LPS + Hypoxia p value
Dopamine (µg/kg/min) 2.6 (1.9) 3.6 (2.1) 8.9 (8.3) 13.4 (6.0) 0.12
Dobutamine (µg/kg/min) 0 (0) 0 (0) 4.8 (7.0) 4.8 (4.8) 0.33
Noradrenaline (ng/kg/min) 0 (0) 0 (0) 34.9 (56.4) 18.6 (19.0) 0.44
Adrenaline (ng/kg/min) 0 (0) 0.9 (1.9) 147.9 (229.8) 169.6 (151.2) 0.30
10 mL/kg Saline Bolus (n) 0 (0) 0 (0) 0.5 (0.7) 0.4 (0.4) 0.10
Table 3. Hemodynamic support requirements. Inotrope and saline bolus use (mean and standard deviation 
(SD)) during experimentation. There was no significant difference between all groups using ANOVA analysis. 
The Hypoxia and LPS + Hypoxia groups required higher doses of dopamine, dobutamine, adrenaline and saline 
than non-hypoxia groups (p ≤ 0.046). There was no effect of LPS on inotrope requirement.
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(p < 0.0001). The Hypoxia group had a greater degree of microglial activation compared to the LPS + Hypoxia 
group (p = 0.007). These changes were consistent throughout the 8 brain regions.
Astroglia. All groups had an increase in astrogliosis versus Naïve (p = 0.005 for Hypoxia, p < 0.0001 for all 
other groups) (Fig. 2d). Throughout all brain regions GFAP staining of reactive astrocytes was maximal for LPS, 
and was greater than each other group on whole brain analysis (p < 0.0001). The Hypoxia group GFAP luminosity 
was lower than Sham and LPS + Hypoxia (p < 0.0001).
An overview of all histological outcome variables is listed in Table 4.
aeeG. All piglets had a normal (score 4) aEEG at baseline (Fig. 4). Mean aEEG score for Hypoxia and 
LPS + Hypoxia was suppressed following insult, and remained suppressed throughout the experiment. There was 
no difference between mean aEEG score at any time point for Hypoxia compared to LPS + Hypoxia. The mean 
aEEG score was <4 in all groups by 52 h; there was a trend towards LPS aEEG score deteriorating earlier than 
Sham. Two Hypoxia piglets had electrographic seizures; one treated with 20 mg/kg phenobarbitone at 6 h post 
insult, and the other untreated at 8 and 12 h post insult. One LPS + Hypoxia piglet received 20 mg/kg phenobar-
bitone at 22 h post insult, followed by 10 mg/kg at 39 h.
Haematology. Serial haematology values are shown in Fig. 5. Total WCC, neutrophil, lymphocyte and 
monocyte counts were stable throughout the experiment in the Sham group. All other groups showed an increase 
in WCC from baseline. The LPS WCC (mainly neutrophils) peak occurred at 12 h (p ≤ 0.03 versus Sham and 
Hypoxia). LPS + Hypoxia had the highest and most sustained increase in WCC from 3 h to 24 h (p ≤ 0.036 com-
pared to Sham and Hypoxia groups). There was a biphasic WCC increase from baseline for Hypoxia, with an 
immediate rise after the insult (p = 0.034), and a second peak at 48 h (p = 0.001), driven mainly by neutrophilia 
Figure 1. TUNEL histology. There was an overall increase in the estimated mean TUNEL+ cells per mm2 
(pooled across region and R0/R1 levels) in the LPS + Hypoxia group versus all other groups (a). Representative 
sections are shown at x40 magnification from the internal capsule (b). A TUNEL+ cell is arrowed. On regional 
assessment, there was an increase in TUNEL+ cells for LPS + Hypoxia in the IC and PvWM versus Naïve, Sham 
and LPS, and in the sCTX versus Naïve and LPS (c). Cingulate cortex = cCTX; Sensorimotor cortex = sCTX; 
Hippocampus = HIP; Periventricular white matter = PvWM; Internal capsule = IC; Caudate = CAUD; 
Putamen = PTMN; Thalamus = THAL. Error bars represent standard error. ****p < 0.0001, ***p < 0.001,  
**p < 0.01, *p < 0.05.
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Figure 2. Estimated mean whole brain (left) and regional (right) cleaved caspase-3 (a), IBA1 cell count 
(b), IBA1 ramification index (c) and GFAP luminosity (d). CC3 positive cells markedly increased with LPS 
exposure. There was no effect of hypoxia in isolation on CC3. In combination, the increase in CC3 with 
LPS was attenuated by hypoxia exposure. Microglia number (IBA1 count) was increased by LPS exposure, 
whilst microglial activation (IBA1 ramification index) was increased by hypoxia exposure. Astrogliosis was 
increased from Naïve for all groups, maximal for LPS. Cingulate cortex = cCTX; Sensorimotor cortex = sCTX; 
Hippocampus = HIP; Periventricular white matter = PvWM; Internal capsule = IC; Caudate = CAUD; 
Putamen = PTMN; Thalamus = THAL. Error bars represent standard error. ****p < 0.0001, ***p < 0.001, 
**p < 0.01, *p < 0.05.
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(p ≤ 0.002 versus Sham and LPS). Lymphocyte count increased for LPS + Hypoxia, peaking at 24 h (p = 0.005), 
later than the 3 h neutrophil peak. On post hoc analysis, peak WCC modestly correlated with TUNEL+ cell count 
(r = 0.57, p = 0.014) and with IBA1 ramification index (r = −0.64, p = 0.004). There was no correlation between 
peak WCC and any of GFAP (rs = −0.26), IBA1 count (r = −0.40) or CC3 (rs = −0.15).
Compared to baseline, Sham and Hypoxia developed a thrombocytosis, with a significant elevation from 
24 h for Sham and from 12 h for Hypoxia (p ≤ 0.014). LPS infusion suppressed this rise in platelets: at all time 
points after baseline, the mean platelet counts for the LPS treated groups (LPS and LPS + Hypoxia) were lower 
Figure 3. Representative IBA1 stained microglia in the cingulate cortex at x40 magnification, for Naïve (a), 
Sham (b), LPS (c), Hypoxia (d) and LPS + Hypoxia (e). In non-disease states, microglia have small cell bodies 
and multiple fine branches. LPS exposure subjectively increased branch thickness, while hypoxia induced 
amoeboid change.
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than non-LPS groups (p ≤ 0.03). Following an initial increase, haemoglobin was lower than baseline in both LPS 
treated groups from 24 h onwards (p < 0.001).
Spleen weight. There was no difference in spleen weight across all groups on ANOVA analysis. Spleen 
weight of those piglets treated with LPS (LPS and LPS + Hypoxia) suggests splenic hypertrophy when compared 
with non-LPS treated piglets (Sham and Hypoxia) −2.4 ± 0.4 g/kg body weight, versus 1.3 ± 0.2 g/kg body weight, 
(p = 0.006). There was no effect of hypoxia on spleen weight.
Discussion
Bacterial LPS commenced 4 h prior to hypoxia and continued for 48 h in the newborn piglet resulted in an 
increase in mortality and an exacerbation of brain cell death compared to hypoxia alone. LPS alone did not 
increase cell death, but resulted in the greatest increases in microglial proliferation, reactive astrocytosis and 
cleavage of caspase-3. EEG recovery was suppressed by hypoxia, with no additional effect of LPS. LPS in both 
the non-hypoxia and hypoxia groups was associated with a suppression of platelet count. The spleen weight was 
greater in the LPS exposed groups, suggesting activation of the systemic immune response.
Our immunohistochemistry (TUNEL) findings are consistent with previous clinical studies which link 
antepartum inflammation with an increased risk of NE and brain injury following HI. For example, histological 
chorioamnionitis was found in 46% of placentae from one NE cohort, in comparison to 18% of healthy term 
Sham LPS Hypoxia LPS + Hypoxia
TUNEL+ cell death — —
Caspase-3 cleavage —
Microglia count — —
Microglial activation — —
Astrogliosis
Table 4. Histology summary. An overview of histological outcome measures. A dash demonstrates no 
difference to Naïve. A single arrow represents an increase above Naïve. A double arrow represents an increase 
compared with the single arrow group, and a triple arrow an increase above the double arrow group.
Figure 4. Mean aEEG score from baseline (BL) till 48 h, divided into 6 h time epochs (a), using pattern 
classification scoring system (b), where 0 = flat trace, 1 = low voltage, 2 = burst suppression, 3 = discontinuous 
normal voltage, and 4 = continuous normal voltage. After insult, Hypoxia group had lower scores than Sham at 
all time points (p ≤ 0.025), and than LPS until 36 h (p ≤ 0.021). LPS + Hypoxia had lower scores than Sham at all 
time points, except 25–30 h (p ≤ 0.038); and than LPS from 0–12 h, and again at 43–48 h (p ≤ 0.033). There was 
no difference between Hypoxia and LPS + Hypoxia. Phenobarbitone was given to one Hypoxia piglet at 6 h post 
insult (20 mg/kg), and one LPS + Hypoxia piglet at 22 h (20 mg/kg) and 39 h (10 mg/kg) post insult. Error bars 
represent standard error. *p < 0.05 vs. Sham (*colour denotes group), †p < 0.05 LPS vs. Hypoxia, ‡p < 0.05 LPS 
vs. LPS + Hypoxia. Yellow arrows along the x-axis represent approximate time of death of the 3 LPS + Hypoxia 
subjects who died prematurely.
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infants from the same region13. Funisitis increases risk of NE in both high- (OR 9.29 (95% CI 1.36–63.06))32 and 
low- resource settings (OR 11.8 (95% CI 2.19–63.45))15. Neonatal bacteraemia has also been associated with 
an increased risk of NE15,33. Indeed, a number of observational studies suggest the risk of neurodevelopmental 
Figure 5. Change in haematology parameters throughout experimentation. WCC and platelet count analysis 
included between group comparisons at each time point. Error bars represent standard error. BL = baseline; 
β p < 0.05 change from BL (β colour denotes group), *p < 0.05 vs. Sham at same time point (*colour denotes 
group), †p < 0.05 LPS vs. Hypoxia, ‡p < 0.05 LPS vs. LPS + Hypoxia, #p < 0.05 Hypoxia vs. LPS + Hypoxia. 
Yellow arrows along the x-axis represent approximate time of death of the 3 LPS + Hypoxia subjects who died 
prematurely.
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impairment after inflammation-sensitized HI is high7,8,18,32. The risk of developing CP is markedly increased 
with the combination of antenatal infection and a potentially birth-asphyxiating condition, compared to either 
in isolation (OR 78 (95% CI 4.8–406), versus OR 7.2 (95% CI 2.7–20) and 2.5 (95% CI 1.0–6.7) respectively)18. 
Similarly, chorioamnionitis in combination with MRI evidence of HI injury increases risk of CP (OR 17.5 (95% 
CI 3.3–93.4))8. In NE infants, raised pro-inflammatory cytokines at birth are associated with an increase in mor-
tality and poor neurodevelopmental outcome16,17,34. In a large multicentre meta-analysis, mortality amongst 
infants with both Group B streptococcal sepsis and NE was higher than for infants with NE alone (21% compared 
with 13.7%, RR 2.07 (95% CI 1.47–2.91))33. We found a similarly increased mortality rate amongst our piglets 
with NE and inflammation.
The mechanism by which short-term preceding inflammation increases brain vulnerability to HI is com-
plex. Pathways depend upon pathogen and timing of exposure. Gram-negative organisms and LPS act via TLR4 
receptors, whilst gram positive organisms predominantly act via TLR2 receptors35. LPS, and other TLR ago-
nists, increase the susceptibility to term HI in rodent models19,21,24,36. In models of LPS sensitized NE, TLR4 
binding triggers many self-perpetuating pathways, including Myd88 dependent induction of nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB), microglial activation/proliferation and release of 
pro-inflammatory cytokines, including primary mediators of injury, interleukin 1 (IL-1) and Tumour necrosis 
factor alpha (TNFα)5,19,22,24,37–41. Activation of TLR4 by LPS before hypoxia is thought to suppress mitochondrial 
respiration, leading to a cumulative larger ATP depletion during hypoxia. Cells with decreased mitochondrial 
respiration are more vulnerable to glutamate excitotoxicity42. Additionally, LPS has been associated with in an 
increase in cyclooxygenase prostaglandin E2 pathway mediated brain injury and with early neutrophil infiltra-
tion23,37,43. Endogenous glucocorticoid stress response to LPS also contributes to neuronal injury37,44. Speculation 
following rodent studies19, that LPS increases brain injury by inducing hypotension prior to HI, is not supported 
by the results of this study; pre-hypoxia MABP was stable after 4 h of LPS, and higher in the LPS compared with 
saline treated piglets.
The timing of inflammation prior to an insult is important as shown in other animal models. In a rodent 
model, LPS 12 h prior to insult resulted in maximal tissue loss compared with earlier or later administration24. 
Eklind et al. demonstrated neuroprotection with LPS given 24 h prior to insult and injury exacerbation with LPS 
given 6 h or 72 h prior to insult in rodent pups45. Protective pre-conditioning with chronic LPS has been replicated 
in the rodent46 and preterm lamb47,48. The most frequently studied time interval between LPS and HI in the rodent 
has been 4h19,20,24,41,44,49,50. This time interval in the rodent is difficult to extrapolate to the clinical setting given the 
rodent’s accelerated life cycle. In this piglet study, we gave LPS 4 h prior to hypoxia, to validate the rodent studies. 
Only 4 h sensitization was modelled in our study.
Available evidence strongly supports that perinatal infection and inflammation can cause neurological stress 
and injury without a sentinel event. Neonates exposed to maternal infection are more likely to have low Apgar 
scores7, and those with sepsis demonstrate abnormal neurological symptoms in 63% of cases51. Amongst infants 
exhibiting NE, those without MRI evidence of HI injury have the greatest proportion of chorioamnionitis and the 
highest C-reactive protein levels13, suggesting encephalopathy due to infection and inflammation, rather than a 
sentinel event. On multivariate analysis, chorioamnionitis in isolation of birth asphyxia is independently associ-
ated with CP7–9,18. Surprisingly, in our study LPS only piglets had similar levels of TUNEL+ cell death to Naïve 
and Sham. This was despite evidence suggestive of a neuroinflammatory response, with the highest levels of reac-
tive astrogliosis, microglial number and cleavage of caspase-3. These latter three processes may trigger a cascade 
of brain injury over a longer time period than the 52 h observed in our study52.
The dose of LPS used for this study was sufficient to cause a systemic response, as evidenced by a tachycardia 
in the two LPS groups at 4 h and increase in WCC. Temperature instability was not seen due to strict control by 
the Tecotherm mattress. There was a trend towards an earlier deterioration of the aEEG for LPS piglets compared 
with Sham. LPS, with and without hypoxia, resulted in an increase in circulating neutrophils and splenic hyper-
trophy, suggestive of activation of the adaptive immune system. In addition, LPS suppressed thrombocytosis; this 
may be related to platelet consumption and release of megakaryocyte inhibitors by activated platelets as occurs 
clinically in neonates with infection53.
Cleavage of caspase-3 was markedly increased in the LPS group, despite a low TUNEL+ count. Upregulation 
of CC3 by LPS without increased cell death has been reported54,55, and may be linked to alternative immune roles 
of caspases, including microglial and lymphocyte proliferation/function, cell differentiation and autophagy56–58. 
Astrogliosis, measured by GFAP, was also maximal in the LPS group and higher in LPS + Hypoxia than Hypoxia 
group; this may reflect the LPS-triggered TNFα, IL-1ß and IL-6 release, which are mediators of astrocyte prolif-
eration and activation38,59,60.
Microglial cell counts were highest for LPS and LPS + Hypoxia groups, likely due to chemokine induced 
microglial proliferation by LPS. Unexpectedly, hypoxia alone did not increase microglial number61,62. Microglial 
activation state, considered important in quantifying the cell’s inflammatory response5,22, was most marked 
with Hypoxia alone followed by LPS + Hypoxia, the two groups with increased TUNEL+ cell death. The pro-
nounced microglial activation with Hypoxia relative to LPS + Hypoxia may be related to a possible counteracting 
‘hyper-ramification’ effect of LPS, previously demonstrated in adult mice63 or because there was insufficient time 
for microglial activation to evolve in the LPS + Hypoxia piglets who died prematurely64. The inverse relationship 
between Hypoxia and LPS + Hypoxia for cell death and microglial activation highlights the complex role that 
activated microglia contribute to both injury (an M1 pro-inflammatory phenotype) and neuroprotection and 
repair (an M2 anti-inflammatory restorative phenotype)5,61,65,66.
For both Hypoxia and LPS + Hypoxia, the increase in TUNEL+ cell death was without an increase in CC3. 
CC3 cell count was not correlated with TUNEL+ cell count. This suggests the observed TUNEL+ cell death 
occurred by processes independent of caspase 3, such as necrosis, necroptosis57, and non-caspase mediated apop-
tosis (for example, via the apoptosis inducing factor pathway)67. The Hypoxia group had reduced GFAP compared 
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with Sham reflecting hypoxic astroglial injury. This reduction in GFAP/astroglial density at 48–72 h post HI has 
been demonstrated in the piglet previously, with subsequent recovery at 96h68,69. Hypoxic injury may also account 
for the reduction in GFAP, CC3 and microglial count seen for LPS + Hypoxia relative to LPS alone.
The Sham group demonstrated an increase in astrogliosis and CC3 in comparison with Naïve. The Sham and 
Naïve group differ in postnatal age at death, and in experimental intervention. GFAP expression increases with 
advancing maturity in the rodent70, pig71 and human72 brain, although it is unknown if 52 h maturation is suffi-
cient justification for the incremental change seen here. We have previously demonstrated that surgery (tracheos-
tomy) and brief anaesthesia (6 h isoflurane and fentanyl) is sufficient to mildly increase CC3 and TUNEL+ cells 
in the piglet73. Our current study was not powered to detect small differences in TUNEL+ count.
In this hypoxia model TUNEL+ staining was increased in the internal capsule, periventricular white matter 
and sensorimotor cortex, consistent with a watershed injury pattern seen in babies74 and primates75 typically fol-
lowing ‘prolonged partial asphyxia’; this injury pattern corresponds to specific motor76 and neurodevelopmental 
outcomes in children77. Our previous studies involved a hypoxic-ischemic insult induced by transient carotid 
artery occlusion; the pattern of injury was typically deep grey matter which is consistent with a sentinel event26,28. 
In comparison to previous studies using the carotid occlusion HI insult26, piglets were systemically more unstable, 
particularly in the LPS + Hypoxia group in which 3 out of 5 piglets died around 24 h. This reflects the systemic 
injury from global hypoxia and the contribution of LPS to systemic organ dysfunction.
There are some limitations to this study. This was a novel insult, without carotid occlusion or MRS cerebral 
metabolism monitoring78; this was aimed towards a more controlled insult and enabled continuous EEG. Despite 
new methodology and a lack of allocation concealment, we were able to maintain consistency in insult severity 
between the two hypoxia groups, as evidenced by similar insult parameters. There was a trend towards a shorter 
aEEG isoelectric recording in the LPS + Hypoxia group; this is likely to reflect the reduced tolerance to hypoxia 
in the LPS + Hypoxia group. Inotrope and phenobarbitone use, both potential mediating variables, were similar 
between the two hypoxia groups. The contribution of phenobarbitone to histological brain injury is unclear, with 
both neuroprotection and worsening of histological brain injury demonstrated following its use in preclinical 
neonatal models79–81. The Hypoxia group had a mildly elevated baseline pH of 7.55. The normal mean arterial 
pH for a piglet is 7.582 so it is unlikely this had a meaningful biological effect. Other between-group differences in 
physiological parameters, excluding those immediately post insult, were within expected ranges and unlikely to 
affect outcome measures. Two piglets, one LPS and one Hypoxia, had brief respiratory arrests during experimen-
tation. This may have contributed to in an increase in brain injury, which would result in an underestimation of 
the difference to the LPS + Hypoxia group.
The sample size is a study limitation. With this number of subjects we are only able to detect large differences 
in TUNEL+ cell death. Smaller but still potentially meaningful differences, for example between LPS and Sham/
Naïve are not able to be determined. Given the small sample size, only male piglets were used to reduce intergroup 
variation. We were therefore not able to examine the increasingly recognized impact of sex on NE/HI outcome83. 
Inclusion of both sexes is a necessary area for future development of the model, and will require larger group 
sizes. The small sample size was compounded by the premature mortality in the LPS + Hypoxia group, resulting 
in heterogeneous duration of LPS exposure and time since hypoxia at histological specimen collection, and only 
n = 2 for EEG, physiology and haematology data after 24 h. We perceived the risk of ongoing mortality was high 
for this group, therefore further studies were considered unethical. Our future experiments using an LPS NE 
model, will change the insult protocol to use carotid occlusion which will reduce the burden of systemic hypoxia 
and will likely reduce animal losses.
We used bacterial LPS injection in this study and so modelled only gram-negative infection/endotoxae-
mia. Although gram-positive organisms are the most common cause of peripartum sepsis in high resource 
settings, gram-negative neonatal sepsis is increasing in frequency due to antibiotic prophylaxis84. In low- and 
middle-resource settings, gram-negative organisms, such as Klebsiella species and E. coli, surpass gram-positive 
organisms as the leading causative pathogens in neonatal sepsis85,86. Interestingly, the response to therapeutic 
hypothermia (HT) with sensitization from gram negative and positive organisms differs in rodent models. In a 
rodent HI model, prior LPS or PAM3CSK4 (a TLR2 agonist) caused a similar degree of brain injury21, but only 
the PAM3CSK4 sensitized rodents benefitted from HT20,21. A small observational study suggested HT for NE may 
be less protective with chorioamnionitis87. Indeed it is possible that HT may be harmful in the setting of infec-
tion88–90. In babies, HT causes chemokine-associated immunosuppression, with reduced peripheral leucocyte 
numbers, associated with a poorer long-term outcome if persisting after rewarming91. Furthermore, TH alters 
temporal cytokine profile34; reduces microglial activation27 and lowers blood pressure92, potentially contributing 
to injury and systemic instability in inflammation-sensitized NE. Large animal studies investigating the efficacy 
and safety of HT and other potential neuroprotective agents in inflammation-sensitized HI are required.
Our pre-clinical study gives a biological basis for the higher mortality and severe neurological outcome seen 
in babies with inflammation-sensitized NE. To optimize outcomes, it will be important to detect these babies, so 
that optimal therapies might be given. aEEG did not differentiate hypoxia from inflammation-sensitized hypoxia: 
both caused sustained aEEG depression. Suppression of thrombocytosis differentiated LPS exposure. WCC peak 
at 3 h discriminated LPS + Hypoxia from other groups, but the elevation was only moderate and still within the 
normal range; WCC peak was only modestly correlated with TUNEL+ cell death and microglial activation. 
Protein and gene expression show promise in delineating inflammation sensitization and may help to target neo-
natal therapies according to inflammation profile93.
We have shown in the newborn piglet undergoing intensive care support over 52 h, that LPS sensitization 4 h 
prior to hypoxia resulted in an increase in mortality and in overall brain cell death (TUNEL+ cells), mainly in 
the internal capsule, periventricular white matter and sensorimotor cortex. Our findings concur with data from 
rodent models; cell death following LPS-sensitized hypoxia was greater than combined cell death from hypoxia 
alone and LPS alone. In isolation, LPS did not increase cell death compared to naïve brain but LPS exposure alone 
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resulted in the greatest increases in microglial proliferation, reactive astrogliosis and cleavage of caspase-3. EEG 
recovery was suppressed by hypoxia, with no additional effect of LPS. The evolution of white cell and platelet 
count throughout experimentation differentiated exposure to LPS and hypoxia with a suppression in thrombocy-
tosis with LPS. Given the significant risk of adverse outcomes with co-existing inflammation and birth asphyxia, 
it will be important to determine the impact of HT and other neuroprotective interventions in this LPS-sensitized 
piglet model, to guide future clinical studies.
Methods
The study was conducted according to UK Home Office Guidelines [Animals (Scientific procedures) Act, 1986] 
and complies with the ARRIVE guidelines. The study was approved by the Ethics Committee of UCL.
sample size calculation. Using previous piglet data, and 2 LPS pilots, we estimated that 5 piglets per inter-
vention group were required to detect a difference in TUNEL+ cells of 45 cells/mm2, using a significance thresh-
old of 5% and 80% power. Owing to lower anticipated variability, and to minimize animal use in accordance with 
ARRIVE guidelines, only 3 piglets were determined to be required in the Sham group.
Animal experiments and surgical preparation. Male Large White piglets aged <36 h were included. 
Piglets were sedated with intramuscular midazolam (150 µg), and arterial O2 saturation monitored (Nonin 
Medical, MN, USA). The Naïve group (n = 7) was euthanized immediately following midazolam, within 10 min-
utes of arrival to the facility. Remaining piglets were anesthetized and surgically prepared. Isoflurane anaesthesia 
(3% v/v) was given to facilitate tracheostomy (Smiths Medical, Kent, UK) and was maintained (2–3%). Piglets 
were mechanically ventilated (SLE 2000, Surrey, UK) with PEEP 5, PIP 20 and inspiratory time 0.5 seconds; 
Fraction of inspired oxygen (FiO2) and respiratory rate were adjusted to maintain partial pressure of oxygen 
(PaO2) and carbon dioxide (PaCO2) at 8–13 kPa and 4.5–6.5 kPa, respectively.
A 4 French double-lumen umbilical venous catheter (Vygon, Swindon, UK) was inserted for infusion of main-
tenance fluids (10% dextrose, 60 ml/kg/day, reduced to 40 ml/kg/day post insult), fentanyl (3 μg/kg/h) and anti-
biotics (benzylpenicillin 50 mg/kg every 12 h and gentamicin 4 mg/kg every 24 h). A 2 French central venous 
catheter (Vygon) was sited in the axillary or brachial vein for infusion of LPS or saline. A 2.5 French umbili-
cal arterial catheter (Vygon) was inserted for continuous monitoring of heart rate and arterial blood pressure 
(MABP), and intermittent blood sampling (Abbot Laboratories, UK). Arterial lines were maintained by infusing 
0.9% saline solution (0.3 mL/h) with 1 IU/mL heparin.
Duration of surgery was 1–2 h, after which piglets were positioned prone. A post–surgery blood gas was taken 
to ensure no intraoperative hypoxia or hypoperfusion. All piglets received continuous physiological monitoring 
(SA instruments) and intensive life support throughout the study. Rectal temperature was maintained in the 
normothermic range (38.0–39.0 °C) for all piglets for the duration of the experiment, using a radiant warmer 
during surgery and subsequently a heated water mattress (Tecotherm). Infusions of crystalloid (0.9% saline, 
10 mL/kg bolus, prn, maximum once daily) and inotropes (escalation protocol using dopamine 5–25 μg/kg/
min, dobutamine 5–20 μg/kg/min, noradrenaline 0.1–1 μg/kg/min, and adrenaline 0.1–1 μg/kg/min) maintained 
MABP >35 mmHg. Hyperkalaemia, hyperglycaemia and metabolic acidosis were managed in accordance with 
clinical neonatal guidelines.
experimental groups. Approximately 1 h following surgery and baseline recordings, piglets were rand-
omized by computer generated sequence to (i) Sham (n = 3); (ii) LPS (LPS, n = 5); (iii) Hypoxia (Hypoxia, n = 6); 
and (iv) LPS and Hypoxia (LPS + Hypoxia, n = 5) (Fig. 6). LPS and LPS + Hypoxia piglets were given a bolus of 
2 μg/kg LPS (Escherichia coli (E. coli), Sigma LPS O55:B5) followed by a continuous infusion of 1 μg/kg/h LPS 
for the duration of the experiment. Sham and Hypoxia piglets had a matched bolus of 0.9% saline (0.5 ml/kg), 
followed by a continuous saline infusion (0.25 ml/kg/h).
Hypoxic insult. After the 4 h infusion, Hypoxia and LPS + Hypoxia piglets underwent a global hypoxia 
insult. FiO2 was reduced in a stepwise fashion to 4% over 3 minutes and held for 10 minutes. This was followed 
by a further 10 to 30 minutes of FiO2 6–12% titrated to standardized parameters, including MABP 26–30 mmHg, 
and sustained isoelectric EEG (<5 uV). The insult was terminated if cardiac arrest was imminent indicated by 
profound hypotension or bradycardia.
eeG acquisition. Multichannel six-lead EEG (Nicolet, Care Fusion, Wisconsin, USA) was acquired at base-
line and continued throughout. aEEG recordings were classified hourly according to the pattern classification94 
by 2 experienced clinical assessors (KM and IL), blind to treatment allocation. A score of 0 was given for flat trace; 
1 continuous low voltage; 2 burst suppression; 3 discontinuous normal voltage and 4 continuous normal voltage. 
Each piglet’s scores were averaged over 6 h periods. Seizure activity was quantified. Electrographic seizures were 
treated with Phenobarbitone, in accordance with clinical neonatal guidelines.
Haematology. Arterial blood samples were collected at baseline, 4 h after LPS/saline bolus, at end of hypoxic 
insult (or equivalent time for non-hypoxia piglets), and at 3, 12, 24 and 48 h post insult time. Samples were 
stored at 4 °C for a maximum of 72 h, and underwent external blinded complete blood film examination (Royal 
Veterinary College, Hawkshead, UK). Analyses included total white cell (WCC), neutrophil, lymphocyte, mono-
cyte and platelet count and haemoglobin.
Brain Histology. 52 h after bolus (48 h post hypoxic insult for Hypoxia and LPS + Hypoxia groups), pig-
lets were euthanized using pentobarbital (1 g/kg). Organs were fixed through a transcardial perfusion with cold 
phosphate-buffered saline, followed by 4% phosphate-buffered paraformaldehyde. The spleen was removed and 
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weighed prior to paraformaldehyde perfusion. The brain was dissected out and post fixed at 4 °C in 4% paraform-
aldehyde for 7 days. Coronal slices (5 mm thick) of the right hemisphere were embedded in paraffin wax and 
sectioned (5 µm thick). For each animal, 2 sections, one taken through the hippocampus (R1), and another 5 mm 
anterior (R0) were assessed for each stain.
To quantify histological cell death, sections were stained for nuclear DNA fragmentation using histo-
chemistry with Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL). In addition, apop-
tosis was assessed by Cleaved Caspase-3 (CC3) immunoreactivity. Glial activation was quantified using 
astrocyte Glial Fibrillary Acidic Protein (GFAP) and microglial ionized calcium-binding adaptor molecule 
(IBA1) immunoreactivity.
For all histochemical and immunohistochemical stains, brain sections were dehydrated in xylene (3 × 10 min) 
and rehydrated in graded ethanol solutions (100–70%), followed by double-distilled water. For TUNEL, the sec-
tions were pre-treated for 15 min in 3% H2O2 in methanol to remove endogenous peroxidase, followed by a 
15-min peptidase pre-digestion with 20 µg/mL proteinase K (Promega) at 65 °C, and then incubated at 37 °C for 
2 h with the TUNEL solution (Roche) containing biotinylated dUTP. For CC3 and IBA1, pre-treatment was per-
formed with Ventana CC1 (950-124), equivalent to EDTA buffer, for 32 min. For GFAP, Protease 1 (0.38 mg/mL 
alkaline protease enzyme activity), for 4 min was used. Incubation with primary rabbit antibody was performed 
against CC3 (1:100) (Cell Signalling 9661 L) for 32 min, IBA1 (1:250) (WAKO 019-19741) for 4 h or GFAP 
(1:1000) (DAKO Z0334) for 32 min. Incubation with a secondary swine anti-rabbit immunoglobulin (DAKO 
E0343) was performed for either 44 min (CC3), 1 h (IBA1) or 32 min (GFAP).
The biotin residues were detected with the avidin-biotinylated horseradish peroxidase complex (ABC, Vector 
Laboratories) and visualized with diaminobenzidine/H2O2 (Sigma), with CoCl2 and NiCl2 included to intensify 
TUNEL histochemistry. The sections were dehydrated in graded alcohol and xylene and mounted with Depex 
(VWR), or alternatively, mounted with Vectashield + 4′,6-diamidino-2-phenylindole (DAPI) aqueous mounting 
media (Vector Labs), to facilitate total cell number counts during analysis of IBA1 and CC3.
Investigators blind to the treatment group performed analyses in 8 brain regions (cingulate cortex, sensorimo-
tor cortex, hippocampus, periventricular white matter, internal capsule, caudate nucleus, putamen and thalamus). 
For each section and brain region, TUNEL+ nuclei were counted in three fields (at x40 magnification, with an 
area of 0.066 mm2) and the average converted into counts per mm2.
IBA1 positive cell body count was similarly performed. In addition, IBA1 positive microglial cell bodies and 
branch density were calculated at x40 magnification using a 0.049 mm × 0.049 mm square grid, placed in three 
fields for all brain regions and counting the number of cell bodies within the grid (C) and the average number of 
branches crossing the 3 horizontal and 3 vertical 0.49 mm gridlines (B). The microglial ramification index was 
calculated as (B2/C).
CC3 immunoreactive cells were counted in three fields (at ×20 magnification with an area of 0.164mm2) and 
the average converted into counts per mm2.
To quantify GFAP immunoreactivity optical luminosity values were calculated by deducting mean brightness 
values of the tissue (three fields per region at x20 magnification) from the mean brightness of the blank region of 
the corresponding slide95.
Figure 6. Study time-line. Following initial weight and wellbeing assessment, 7 piglets were randomly assigned 
to immediate euthanasia (Naïve). Following baseline recordings and tracheostomy, remaining piglets were 
randomized to receive (i) Saline bolus and infusion alone (Sham, n = 3), (ii) LPS bolus and infusion alone (LPS, 
n = 5), (iv) hypoxia 4 h after saline bolus (Hypoxia, n = 6) and (v) hypoxia 4 h after LPS bolus (LPS + Hypoxia, 
n = 5). Blood samples were collected at baseline, 4 h after bolus, end of hypoxia (time 0), and at 3, 12, 24 and 
48 h after time 0. Piglets were maintained under meticulous intensive care for 48 h following hypoxia, prior to 
euthanasia and histological specimen collection. EEG was acquired continuously throughout.
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statistical methods. Using SAS JMP® Pro v14.0.0, analysis of variance models were fitted to give estimates 
of expected treatment group mean values and difference between means for TUNEL (primary outcome measure), 
secondary histology parameters (IBA1, GFAP and CC3), EEG, WCC and platelet count, and also a comparison 
to baseline was calculated for haematology values. Least Squares Means models were used to account for the 
imbalance in treatment group sizes overall and within measures. For TUNEL and other histology measurements, 
the effects of Treatment, Region and the interaction between them were fitted to the mean result for each subject 
averaged across replicate measurements within each region. For EEG and haematology, a model with terms for 
Treatment, Time Interval (as a factor) and the interaction between them, and a random subject effect to take 
into account the repeated measures structure was fitted to the results for each subject averaged across each time 
interval. Least square means are shown graphically with standard error bars. Using GraphPad Prism® v7 software, 
Tukey-Kramer multiple comparisons correction was applied for between group regional comparisons of second-
ary histology outcome parameters. Post hoc Pearson’s (r) or Spearman’s (rs) correlation between histological and 
haematology parameters were performed using IBM SPSS® v22 software. Physiological data were analysed with 
IBM SPSS® v22 software, using ANOVA and Tukey-Kramer multiple comparison correction for group compari-
sons and T test or Mann Whitney U test as appropriate for pairwise comparisons.
Data Availability
The datasets used and/or analysed during the current study are available from the corresponding author on rea-
sonable request
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